Capital - Disclosure of number and weighted average exercise prices of other equity instruments (Details)
|
|
12 Months Ended |
|
|
Jun. 30, 2025
shares
|
Dec. 31, 2025
share
|
Jun. 30, 2026
shares
€ / shares
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) | share |
|
3,479,983
|
|
| Warrants |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
18,985,724
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
6,738,324
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
5,891,757
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
6,355,643
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
6,355,643
|
| BSAAR 2011 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
650,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
25,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
625,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 2.04
|
| BSAAR 2012 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
146,050
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
12,250
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
133,800
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 2.04
|
| BSAAR 2015 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
1,050,382
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
1,048,442
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
1,940
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 7.20
|
| AGAP Management 2016-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
2,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
1,300
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
700
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Employees 2016-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
2,486
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
1,021
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
1,465
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Management 2016-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
50,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
50,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Management 2016-2 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
3,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
3,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Management 2016-2 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
250,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
250,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Employees 2017-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
5,725
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
5,725
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Management 2017-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
2,400
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
2,400
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Employees 2017 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
114,500
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
4,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
110,500
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Bonus 2018-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
67,028
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
469
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
66,559
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Perf Employees 2018-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
327,500
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
224,375
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
103,125
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Perf Management 2018-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
260,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
150,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
110,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Employees 2018 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
90,650
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
5,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
85,650
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA New Members 2017-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
25,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
25,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Bonus 2019-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
57,376
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
57,376
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP 2019 Employees 2019 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
546,700
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
375,150
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
171,550
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP 2019 Management 2019 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
355,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
207,500
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
147,500
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Bonus 2020-1 & 2 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
79,861
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
17,885
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
61,976
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Employees 2020-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
766,650
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
681,420
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
85,230
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Management 2020-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
710,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
580,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
130,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Bonus 2021-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
125,748
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
125,748
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Employees 2021-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
1,066,600
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
454,520
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
612,080
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGAP Management 2021-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
610,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
194,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
416,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA "Plan Epargne Entreprise" 2022 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
138,960
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
138,960
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Bonus 2022-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
128,061
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
128,061
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Employees 2022-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
1,371,500
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
400,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
971,500
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Management 2022-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
550,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
550,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA "Plan Epargne Entreprise" 2023 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
163,293
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
163,293
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA New members 2023-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
25,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
25,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
25,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Employees 2023-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
1,403,500
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
543,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
860,500
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
860,500
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Management 2023-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
750,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
300,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
450,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
450,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA New members 2024-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
25,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
25,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA "Plan Epargne Entreprise" 2024 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
68,744
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
68,744
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Management 2024-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
150,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
150,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
150,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA employees 2024-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
370,560
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
101,160
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
269,400
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
269,400
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Employees 2024-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
1,162,900
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
339,500
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
823,400
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
823,400
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Management 2024-2 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
975,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
450,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
525,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
525,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Management 2024-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
200,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
200,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
200,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA 2025-01 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
220,500
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
61,100
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
159,400
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
159,400
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA 2025-02 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
432,162
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
13,167
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
418,995
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
418,995
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Management 2025 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
18,750
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
18,750
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
18,750
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Employees 2025-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
1,296,438
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
39,500
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
1,256,938
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
1,256,938
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| AGA Perf Management 2025-2 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
1,065,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
1,065,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
1,065,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| Stock Options 2020-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
102,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
102,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 0
|
| Stock Options 2024-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
100,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
100,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 2.18
|
| BSA 2011-2 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
225,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
25,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
200,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 1.77
|
| BSA 2013 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
237,500
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
12,500
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
225,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 2.36
|
| BSA 2014 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
150,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
75,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
75,000
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 8.65
|
| BSA 2015-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
70,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
70,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 9.59
|
| BSA 2015-2 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
14,200
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
14,200
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
0
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
0
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 14.05
|
| BSA 2017 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
37,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
37,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
37,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 11.00
|
| BSA 2022-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
40,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
31,740
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
8,260
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
8,260
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 2.31
|
| BSA 2023-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
50,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
12,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
38,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
38,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 2.26
|
| BSA 2025-1 |
|
|
|
| Disclosure of terms and conditions of share-based payment arrangement [Line Items] |
|
|
|
| Number of free shares granted (in shares) |
80,000
|
|
|
| Number of other equity instruments forfeited in share-based payment arrangement (in shares) |
30,000
|
|
|
| Number of other equity instruments exercised or vested in share-based payment arrangement (in shares) |
0
|
|
|
| Number of other equity instruments outstanding in share-based payment arrangement (in shares) |
|
|
50,000
|
| Number of other equity instruments exercisable in share-based payment arrangement (in shares) |
|
|
50,000
|
| Weighted average exercise price of other equity instruments outstanding in share-based payment arrangement (in EUR per share) | € / shares |
|
|
€ 1.62
|